Speculation regarding the influence of adrenal cortical hormones on body fat has engendered little experimental scrutiny, a deficiency which undoubtedly stems from the difficulties in performing in vivo measurement of the fat content of the body. Fundamental observations of Behnke, Feen, and Welham (1) on the relationship of body fat to body specific gravity suggested the possibility of utilizing serial measurements of body specific gravity for the evaluation of hormonally induced changes in body composition (2) . Measurement of specific gravity by underwater weighing has been used in this laboratory to study the effects of ACTH, Compound E, Compound F and, to very limited degree, of Compound A on body fat (3) . Because of an apparent increase in fat during treatment with Compound F, and because Compound A has been implicated as a fat-affecting hormone, more complete study of these hormones was believed desirable.
METHODS AND MATERIALS
The subject of this study was a 37-year-old white man with chronic dermatitis. He was hospitalized on the metabolic ward for two periods of about 4 months each under conditions of constant activity. The first study was performed when he was moderately depleted and the second study was conducted 15 months later after considerable repletion of fat and protein had been accomplished.
Body weight was measured each morning before breakfast, following completion of the 24-hour urine collection. The patient was given a constant diet containing 2200 calories, 90 grams of protein, 105 grams of fat and 225 grams of carbohydrate. Intake of sodium and potassium was calculated from standard food tables, allowance being made for sodium given as sodium thiocyanate. Rejected portions of the diet were given with the following meal; unfinished portions of the evening meal were given before sleep. The subject was permitted to leave the hospital for a few hours once weekly; there occurred only one major and a single minor violation of the dietary routine at these times. Blood for laboratory analysis was drawn in relatively constant amounts and at regular intervals to provide uniform nitrogen loss by this route. Aliquots of 2-day pooled urine collections were refrigerated until analysis. Urinary nitrogen was measured by a micro-Kjeldahl technique. Nitrogen loss from blood sampling and in stools was estimated to total 1.6 gm. per day. Urinary sodium and potassium were measured by an internal standard flame photometer. Water balance was estimated from the difference between urine output and fluid intake, consisting of the liquid portion of the diet and measured amounts of distilled water.
Body specific gravity was obtained by the method of underwater weighing devised by Behnke, Feen, and Welham (1) as described from these laboratories ( (4) . In correcting for residual lung volume, density of the water was ignored because of the minor error involved as well as the fact that data were obtained from successive measurements of the subject under the same standard conditions. At the time of each measurement underwater weight was obtained during both deep inspiration and full expiration. The difference was checked against measured vital capacity to insure expiration to a relatively constant volume of residual air at each weighing.
Total body fat was estimated by substitution in the Rathbun-Pace equation (5) In all calculations involving total body water the values for antipyrine space were used because these checked much more closely with estimation of total body water by the specific gravity method than did the D20 space.
Measurement of these fluid compartments permitted two methods of correction of hydration abnormality in estimating fat from body specific gravity. One consisted of substitution of the value for body density and that for antipyrine space in the equation derived by Siri where T is corrected thiocyanate space and A is antipyrine space. Change in fat was also determined from the difference between total weight change and the sum of the changes in antipyrine space and nitrogen balance x6.25 (13) .
Density of tissue gained was calculated from the ratio of change in the subject's weight to change in his volume.
Oxygen consumption was measured under fasting conditions by a closed circuit clinical apparatus. The average of two determinations was used in each instance. Urine calcium was measured by the method of Clark and Collip (14) .
Compound A acetate was given intramuscularly in 3 to 4 divided doses each day. Compound F was administered orally every 6 to 8 hours. the control period, became less positive, but only temporarily, when Compound A was started and when the dose was increased. Retention of both water and sodium occurred at these times. Body weight, which was increasing during the control period, rose more sharply during therapy but fell off quickly with the salt and water diuresis which followed cessation of treatment. Body specific gravity was 1.070 at the beginning of treatment -1.068 after the post-treatment diuresis.
The changes with Compound F are depicted in Figure 2 . . These results indicated quite clearly that Compound A has no particular effect on body fat. There did appear to be a significant increase in total body fat during the administration of Compound F. Three possible explanations for these changes were considered: 1) Fat storage occurred only because protein repletion had become complete. Lack of a significant gain in fat during the second control period, when the patient was in approximate nitrogen balance, was a strong argument against this hypothesis.
2) True acceleration of fat deposition had occurred. This possibility, while more plausible than the first, lacked a clear explanation of the mechanisms involved. Insignificant protein catabolism and use of an isocaloric diet throughout the study indicated the absence of liponeogenesis and therefore some change in energy requirements or intermediary metabolism merited consideration.
3) The gain in fat was apparent rather than real because of change in other body constituents. Loss of material of high density, such as bone mineral, in sufficient amounts to cause such a significant change in specific gravity seemed very unlikely. The possibility of abnormal fluid retention could not be entirely discounted for antipyrine space determinations made throughout the study were too variable to permit precise correction for minor hydration abnormality. On the other hand the degree of water and sodium retention during therapy with Compound F appeared no greater than with Compound A, which demonstrated an insignificant effect on body specific gravity.
In view of these possibilities a second study was conducted, utilizing the same metabolic regimen but with the inclusion of multiple measurement of fluid compartments D20 spaces indicated the existence of mild dehydration after the diuresis which followed cessation of treatment. Figure 5 demonstrates the changes in body composition estimated from specific gravity measurements during the entire second study. During the first control period there was increase in weight without significant variation in specific gravity. Administration of Compound F was accompanied on both occasions by more precipitous gain in weight and significant lowering of specific gravity. The fall in weight after cessation of therapy was associated with but little return of specific gravity towards control levels.
As in the first study certain periods were selected for special analysis, chosen at times when minimal hydration abnormality was likely: C1-at the beginning of study; C2-immediately before the first course of Compound F; F1-after the post-treatment diuresis; C3-after a second control period and F2-at the end of treatment.
The results of this study were generally in accord with the first. There occurred significant decrease in specific gravity indicative of substantial increase in fat during the administration of Compound F. Fat increased 1.9 kg. during F1, PERIOD-2 DAYS I 3 5 7 9 11 13 (Figure 4) , there appeared to have been restoration of normal hydration during the second control period, which, because of addition of a material of low density, would indicate gain in fat. This apparent change in hydration suggests that gain of fat during treatment with Compound F was even more pronounced than indicated by the fat estimates derived from these specific gravity data. As shown in Figure 4 oxygen consumption tended to increase during treatment with Compound F and excretion of calcium was insufficient to account for any measurable decrease in body specific gravity. The belief that adrenal horrnones promote an increase in fatty tissue arose from clinical observation of the abnormal body configuration in Cushing's syndrome. Patients with this disorder usually manifest an apparent gain in fat, particularly distributed in the upper third of the body and frequently associated with wasting of the lower extremities. Studies of the relationship of adrenal hormones to body fat in lesser animals are so contradictory and difficult to interpret that complete review is redundant for the purpose of this discussion. Concise summaries of published work on the subject, such as those of Thorn and his associates (17) , Ingle (18) and Engel and Scott (19) indicate that no clear-cut opinion regarding adrenal-fat relationships can be rendered. Studies C2--wF, Fi--*C3 The present study indicates quite definitely that Compound A has no measurable effect on total body fat. There did appear to be a significant and rather substantial gain in adipose tissue during treatment with Compound F. Because of the difficulty in explaining the mechanisms involved and in view of the limited application of these body compositional measurements in clinical investigation, it seems pertinent to re-evaluate the methodology employed before assuming that the gain in fat was real.
As pointed out by Keys and Brozek (11) the specific gravity of the fat free human body cannot be determined with precision. Furthermore, the fat prediction equation utilized in these studies is derived from measurement of small animals, whose proportional body composition and skeletal mass differs from the human subject. It is therefore obvious that a single determination of specific gravity, or even multiple determinations in a metabolically stable subject, cannot provide data which will portray the exact amount of body fat. In conducting serial determinations on a subject of changing fat content, however, a much higher degree of accuracy is possible. In our hands the summation of possible errors, including measurement of residual lung volume, accuracy of scale and reproducibility of replicate determinations indicate that loss or gain of fat must approach 1.5 kg. to be significant. The gains in fat with Compound F observed here were well in excess of that figure.
Apparent gain in fat, as judged by lowering of specific gravity, could also result from addition of other material of low density, such as water, or loss of body constituents of high density, such as protein or minerals. In the study reported here it is obvious that there was insufficient loss of high density body constituents to account for more than a fraction of the specific gravity change. Consequently the existence of significant overhydration remains as the only factor which could lead to distortion of the data sufficient in degree to produce an artifactual gain in body fat. In the first study variation in total body water determinations was of sufficient magnitude to prohibit correction of minor hydration abnormality. However, the changes in weight, sodium excretion and water retention were nearly identical during treatment with Compound A and Compound F and only in the latter instance did there occur a significant change in specific gravity. In the second study more accurate measurement of antipyrine space and the addition of D2O and thiocyanate space measurements provided a clear indication that no significant water retention occurred. In fact, there appeared to be mild dehydration after the diuresis which followed cessation of treatment with Compound F. Such loss of water would tend to minimize the measured gains in body fat which occurred during therapy. Consequently all evidence indicates that the gain in fat was truly significant during treatment with Compound F.
The mechanisms responsible for the increase in body fat are completely obscure. Liponeogenesis from protein obviously did not occur and, as judged by oxygen consumption, there was no decrease in energy production during therapy. Thus we can only postulate some change in intermediary metabolism which permitted the addition of fat without appreciable change in the measured components of the metabolic pool. This supposition obviously lends itself to speculation regarding the hypothesis that some persons, at least under certain circumstances, can maintain their weight or even become obese on a remarkably small caloric intake. Studies of the type reported here should provide more exact data regarding gain or loss of body fat and permit a more objective approach to the problems of obesity.
SUMMARY
Serial determinations of body specific gravity were combined with balance study and measurement of body water compartments to determine the effect of Compounds A and F on body fat. The administration of Compound A for 26 days had no demonstrable effect on body fat. The administration of Compound F for similar periods of time on three separate occasions was associated with a significant increase of total body fat. This gain in fat was not accompanied by evidence of either liponeogenesis from protein or decreased energy production.
